Isolation and Characterization of CTCs from Patients with Cancer of a Urothelial Origin

  • Vladimir BobekEmail author
  • Katarina Kolostova
Part of the Methods in Molecular Biology book series (MIMB, volume 1655)


Monitoring of circulating tumor cells’ (CTCs) presence has the potential to improve therapeutic management of oncological diseases at an early stage and also to identify patients with increased risk of tumor progression or recurrence before the onset of clinically detected metastasis. Here we describe a new simplified efficient methodology for the separation and in vitro culturing of viable CTCs from peripheral blood by size-based filtration (MetaCell®). The isolation protocol yields preferentially cells bigger than 8 μm enabling further cytomorphological and molecular analysis.

Key words

CTCs Circulating tumor cells Prostate cancer Renal Bladder cancer Cultivation In vitro Gene expression 


  1. 1.
    Liberko M, Kolostova K, Bobek V (2013) Essentials of circulating tumor cells for clinical research and practice. Crit Rev Hematol Oncol 88(2):338–356CrossRefGoogle Scholar
  2. 2.
    Zheng Y, Zhang C, Wu J, Cheng G, Yang H, Hua L, Wang Z (2016) Prognostic value of circulating tumor cells in castration resistant prostate cancer: a meta-analysis. Urol J 13(6):2881–2888PubMedGoogle Scholar
  3. 3.
    Gorin MA, Verdone JE, van der Toom E, Bivalacqua TJ, Allaf ME, Pienta KJ (2017) Circulating tumour cells as biomarkers of prostate, bladder, and kidney cancer. Nat Rev Urol 14(2):90–97CrossRefPubMedGoogle Scholar
  4. 4.
    Hu B, Rochefort H, Goldkorn A (2013) Circulating tumor cells in prostate cancer. Cancers (Basel) 5(4):1676–1690CrossRefPubMedCentralGoogle Scholar
  5. 5.
    Hegemann M, Stenzl A, Bedke J, Chi KN, Black PC, Todenhöfer T (2016) Liquid biopsy: ready to guide therapy in advanced prostate cancer? BJU Int 118:855–863CrossRefPubMedGoogle Scholar
  6. 6.
    Kolostova K, Broul M, Schraml J, Cegan M, Matkowski R, Fiutowski M, Bobek V (2014) Circulating tumor cells in localized prostate cancer: isolation, cultivation in vitro and relationship to T-stage and Gleason score. Anticancer Res 34:3641–3646PubMedGoogle Scholar
  7. 7.
    Cegan M, Kolostova K, Matkowski R, Broul M, Schraml J, Fiutowski M, Bobek V (2014) In vitro culturing of viable circulating tumor cells of urinary bladder cancer. Int J Clin Exp Pathol 7(10):7164–7171PubMedPubMedCentralGoogle Scholar
  8. 8.
    Kolostova K, Cegan M, Bobek V (2014) Circulating tumor cells in patients with urothelial tumors: enrichment and in vitro culture. Can Urol Assoc J 8(9–10):E715–E720PubMedPubMedCentralGoogle Scholar
  9. 9.
    Bobek V, Hoffman RM, Kolostova K (2013) Site-specific cytomorphology of disseminated PC-3 prostate cancer cells visualized in vivo with fluorescent proteins. Diagn Cytopathol 41(5):413–417CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media LLC 2018

Authors and Affiliations

  1. 1.Department of Laboratory GeneticsUniversity Hospital Kralovske VinohradyPragueCzech Republic

Personalised recommendations